Alberto Dolce Selected Research

Factor VII Deficiency (Hypoproconvertinemia)

4/2013	Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).
2/2013	Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
2/2011	Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
3/2005	Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Dolce Research Topics

Disease

5	Hemorrhage 12/2019 - 02/2011
4	Factor VII Deficiency (Hypoproconvertinemia) 04/2013 - 03/2005
2	Menorrhagia 04/2014 - 02/2013
2	Thrombosis (Thrombus) 02/2013 - 08/2008
1	Thrombocytopenia (Thrombopenia) 12/2019
1	Multiple Myeloma 05/2015
1	Anemia 04/2014
1	Epistaxis (Nosebleed) 02/2013
1	Body Weight (Weight, Body) 02/2011

Drug/Important Bio-Agent (IBA)

4	Factor VII (Proconvertin)IBA 01/2018 - 03/2005
2	CoagulantsIBA 01/2018 - 06/2013
2	recombinant FVIIa (rFVIIa)FDA Link 02/2013 - 02/2011
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2019
1	factor VII clotting antigenIBA 01/2018
1	Immunomodulating AgentsIBA 05/2015
1	IronIBA 04/2014
1	N 30IBA 02/2013
1	Factor VIIa (Activated Factor VII)IBA 02/2011
1	AnticoagulantsIBA 08/2008

Therapy/Procedure

4	Therapeutics 12/2019 - 02/2011
1	Drug Therapy (Chemotherapy) 12/2019
1	Operative Surgical Procedures 01/2018